Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Vaccines × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Melanoma 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 40 Radiotherapy 18 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Specimen Handling 10 Lomustine 10 Bevacizumab 10 Radiation 7 Cyclophosphamide 5 fludarabine 4 Nivolumab 4 Aminolevulinic Acid 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Ipilimumab 3 regorafenib 2 olaparib 2 fluciclovine F-18 2 atezolizumab 2 antisecretory factor 2 abemaciclib 2 Standard of Care 2 Restraint, Physical 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Palliative Care 2 Oncolytic Virotherapy 2 ONC206 2 Metformin 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04523688 2025-07-22

Combi G-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡